| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/07/2004 | EP1377232A1 Ocular therapeutic agent delivery devices and methods for making and using such devices |
| 01/07/2004 | EP1377227A1 Vessel sealing instrument |
| 01/07/2004 | EP1377183A1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 01/07/2004 | EP1377180A1 Microcapsules |
| 01/07/2004 | EP1221841B1 Encapsulated active material immobilized in hydrogel microbeads |
| 01/07/2004 | EP1098643B1 Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases |
| 01/07/2004 | EP1096923B1 Blister containing a transdermal therapeutic system and a single dose form of administration |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP1067907B1 Ocular irrigating solution |
| 01/07/2004 | EP1033988B1 Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose |
| 01/07/2004 | EP1019024B1 Aerosol ointment compositions |
| 01/07/2004 | EP0973505B1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/07/2004 | EP0969846B1 Compositions and methods for reducing ocular hypertension |
| 01/07/2004 | EP0949925B1 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 01/07/2004 | EP0941071B1 Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| 01/07/2004 | EP0935457B1 Preparation for the transport of an active substance across barriers |
| 01/07/2004 | EP0917457B1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 01/07/2004 | EP0909132B1 Dietetic baby food formula containing conjugated linoleic acids |
| 01/07/2004 | EP0857081B1 Preparation of peptide containing biodegradable microspheres by melt process |
| 01/07/2004 | EP0785775B1 Melt-extruded orally administrable opioid formulations |
| 01/07/2004 | EP0719152B1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | CN2596986Y Prostatitis paster |
| 01/07/2004 | CN1466599A 聚合物水分散体 Aqueous polymer dispersion |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466462A Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and flood compositions containing said extract |
| 01/07/2004 | CN1466461A Antipruritic compositions and compositions promoting wound healing |
| 01/07/2004 | CN1466457A Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 01/07/2004 | CN1466455A Fentanyl composition for nasal administration |
| 01/07/2004 | CN1466452A Composition for the transdermal delivery of fentanyl |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1466450A Dry-powder film coating composition and method of preparation |
| 01/07/2004 | CN1466445A Ultrasonic method and device for wound treatment |
| 01/07/2004 | CN1465392A Violet stem privet leaf ultrafine powder lozenge and productive process thereof |
| 01/07/2004 | CN1465375A Fresh ginger mouth-sucking candy for eliminating ozostomia and preparation method thereof |
| 01/07/2004 | CN1465373A Hypotensor medical threat for treating hypertension |
| 01/07/2004 | CN1465372A Umbilicus plaster for curing stomach-ache |
| 01/07/2004 | CN1465356A Nocar ointment for treating herpes simplex and herpes zoster |
| 01/07/2004 | CN1465349A Fresh pilose antler piece and preparation process thereof |
| 01/07/2004 | CN1465345A Pure natural lecithin soft capsule and preparation method thereof |
| 01/07/2004 | CN1465341A Arginine acetate oral preparation and clinical application thereof |
| 01/07/2004 | CN1465340A Process for preparing thunder godvine nano particle |
| 01/07/2004 | CN1465339A Nano-grade medicine microball and preparation process thereof |
| 01/07/2004 | CN1133472C Device for enhancing transdermal agent flux |
| 01/07/2004 | CN1133466C Gelling ophthalmic composition containing xanthan gum |
| 01/07/2004 | CN1133465C Absorption enhancers for topical pharmaceutical formulations |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/07/2004 | CN1133456C Liquid medicine for curing beriberi |
| 01/07/2004 | CN1133455C Pharyngitis treating Chinese medicine plaster |
| 01/07/2004 | CN1133436C Ultrasonic concentration-difference acid-alkali method for preparing doxorubicin hydrochloride lipid as injection |
| 01/07/2004 | CN1133435C Oral composition containing dehydroepiandrosterone and its sodium sulfate |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133432C Aqueous liquid preparations |
| 01/07/2004 | CN1133430C Release-controlling coating of antineoplastic leurocristine |
| 01/07/2004 | CN1133428C Antibacterial composition for topical administration containing antibiotics |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/07/2004 | CN1133424C Repamycin formulations for oral administration |
| 01/07/2004 | CN1133423C Container with freeze-dried vaccine component |
| 01/07/2004 | CN1133422C Topical application of combination of benzoyl peroxide and second active ingredient |
| 01/07/2004 | CN1133414C Use of nanodispersions in cosmetic end formulations |
| 01/07/2004 | CN1133413C Alpha-hydroxy fatty acid derivatives and cosmetic used composition for external use containing same |
| 01/07/2004 | CN1133405C Products capable of emitting far infrared ray and method for using far infrared ray |
| 01/06/2004 | US6673861 Inverse latices self-invertible with respect to white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane and cosmetic, democosmetic, dermopharmaceutical or pharmaceutical compositions comprising them |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673835 Method and composition for delivering zinc to the nasal membrane |
| 01/06/2004 | US6673826 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering of the skin comprising applying to the skin an oil in water emulsion containing allantoin, an anionic emulsifier and beeswax |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673808 Pharmaceutical consisting of tacrolimus tricyclic compound, diethyl sebacate dissolution/absorption promoter, hydrophilic glycol pharmaceutical base, diethylene glycol monoethyl ether compatibilizer and cellulose or carboxyvinyl polymer thickener |
| 01/06/2004 | US6673805 Platinum derivative pharmaceutical formulations |
| 01/06/2004 | US6673779 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages |
| 01/06/2004 | US6673776 Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| 01/06/2004 | US6673767 Gel composition and methods |
| 01/06/2004 | US6673612 Generation of micelle for the transfer of biopolymers to cells; form cationic reverse micelle using amphipathic molecules, insert bipolymer, adjust the charge of micelle , transfer to cells |
| 01/06/2004 | US6673574 Oral delivery of peptides using enzyme-cleavable membrane translocators |
| 01/06/2004 | US6673382 Containing sugar to provide freezing and thawing stability; foods, drinks; treatment of anemia |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | US6673373 Antifungal formulation and the methods for manufacturing and using the same |
| 01/06/2004 | US6673369 Controlled release formulation |
| 01/06/2004 | US6673367 High speed initial onset of effect and prolonged duration falls rapidly at end of dosing interval so as not to affect the appetite or sleep of patient; side effect reduction |
| 01/06/2004 | US6673366 Breast enhancement system |
| 01/06/2004 | US6673365 Administering hooc-ch2-(r)-cgl-aze-pab where cgl is cyclohexylglycine, aze is azetidine-2-carboxylic acid, and pab is 1-amidino-4-aminomethylbenzene |
| 01/06/2004 | US6673364 Stabilized with distearoylphosphatidyl-ethanolamine (dspe)-polyoxyethylene glycol; determining rate using fluorescent lipid mixing |
| 01/06/2004 | US6673363 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673337 Compositions containing alpha-2-adrenergic agonist components |
| 01/06/2004 | US6673335 Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 01/06/2004 | US6673054 Vitamin incorporated into thermoplastic material |
| 01/06/2004 | CA2227761C Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 01/06/2004 | CA2223588C Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 01/06/2004 | CA2160783C Water based beverages |
| 01/06/2004 | CA2145248C Pharmaceutical compositions containing time-released orally taken trimetazidine |
| 01/06/2004 | CA2096109C Tissue factor based prothrombin time reagent |
| 01/02/2004 | EP1375645A1 Yeast cells as dietary supplements for enhancing the immune system |
| 01/02/2004 | EP1375616A1 Film coating material |
| 01/02/2004 | EP1375497A1 Magnesium salt of s-omeprazole |
| 01/02/2004 | EP1374923A2 Porous implants with antibiotic coating, their preparation and use |
| 01/02/2004 | EP1374904A1 Preparation containing polymethyl-siloxane for nails, cartilage, bone joint, muscle and tendon disorders |
| 01/02/2004 | EP1374903A1 Pharmaceutical composition for the prevention of the development and progression of mycotic skin surface diseases |